administered as a slow IV push or diluted infusion, adjusting per response
TB-500 has been developed to leverage the benefits of thymosin beta-4, focusing on enhancing tissue regeneration, reducing inflammation, and promoting overall recovery
Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin
Product Name: GLOW Blend Strength: 70mg Total Peptide Content Blend Composition: BPC-157 50mg TB-500 10mg GHK-Cu 10mg Classification: Multi-Peptide Research Blend Appearance: Blue-Purple Lyophilized Powder Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Tissue Repair Healing & Inflammation Store lyophilized material refrigerated at 28C for routine storage
Hearing about a peptide on a two-hour episode is not a substitute for the lab evaluation, contraindication screening, and ongoing monitoring that should precede any peptide prescription
Pre-existing Conditions: Patients should discuss with their healthcare provider any history of medical conditions such as epilepsy, migraines, heart, kidney, or liver disease